159 related articles for article (PubMed ID: 8242901)
21. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
Tissandié E; Morelle W; Berthelot L; Vrtovsnik F; Daugas E; Walker F; Lebrec D; Trawalé JM; Francoz C; Durand F; Moura IC; Paradis V; Moreau R; Monteiro RC
Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
[TBL] [Abstract][Full Text] [Related]
22. A polymeric IgA response in serum can be produced by parenteral immunization.
Mascart-Lemone F; Duchateau J; Conley ME; Delacroix DL
Immunology; 1987 Aug; 61(4):409-13. PubMed ID: 3443449
[TBL] [Abstract][Full Text] [Related]
23. IgA Nephropathy: Pleiotropic impact of Epstein-Barr virus infection on immunopathogenesis and racial incidence of the disease.
Mestecky J; Julian BA; Raska M
Front Immunol; 2023; 14():1085922. PubMed ID: 36865536
[TBL] [Abstract][Full Text] [Related]
24. Titres of specific antibodies to poliovirus type 3 and tetanus toxoid in saliva and serum of children with recurrent upper respiratory tract infections.
Cardinale F; Gentile V; Brunetti L; Hanson LA; Armenio L
Pediatr Allergy Immunol; 2001 Feb; 12(1):42-8. PubMed ID: 11251864
[TBL] [Abstract][Full Text] [Related]
25. Increased serum levels of IgA1-IgG immune complexes and anti-F(ab')2 antibodies in patients with primary IgA nephropathy.
Schena FP; Pastore A; Ludovico N; Sinico RA; Benuzzi S; Montinaro V
Clin Exp Immunol; 1989 Jul; 77(1):15-20. PubMed ID: 2788538
[TBL] [Abstract][Full Text] [Related]
26. Disordered balance of IgA subclass production in the tonsils of some IgA nephropathy patients.
Itoh A; Iwase H; Takatani T; Nakamura I; Hayashi M; Kobayashi Y; Hiki Y; Okamoto M
J Nephrol; 2005; 18(5):575-81. PubMed ID: 16299684
[TBL] [Abstract][Full Text] [Related]
27. In vitro regulation of IgA subclass production. III. Selective transformation of IgA1 producing cells by Epstein-Barr virus.
Conley ME; Chan MA; Sigal NH
J Immunol; 1987 Mar; 138(5):1403-7. PubMed ID: 3027178
[TBL] [Abstract][Full Text] [Related]
28. Exaggerated systemic antibody response to mucosal Helicobacter pylori infection in IgA nephropathy.
Barratt J; Bailey EM; Buck KS; Mailley J; Moayyedi P; Feehally J; Turney JH; Crabtree JE; Allen AC
Am J Kidney Dis; 1999 Jun; 33(6):1049-57. PubMed ID: 10352192
[TBL] [Abstract][Full Text] [Related]
29. Mucosal and systemic immune responses of mice to tetanus toxoid coadministered nasally with AFCo1.
Romeu B; González E; Del Campo J; Acevedo R; Zayas C; Valdés Y; Cabrera O; Cuello M; Balboa J; Lastre M; Pérez O
Can J Microbiol; 2011 Mar; 57(3):256-61. PubMed ID: 21358768
[TBL] [Abstract][Full Text] [Related]
30. Intraperitoneal immunization of human subjects with tetanus toxoid induces specific antibody-secreting cells in the peritoneal cavity and in the circulation, but fails to elicit a secretory IgA response.
Lue C; van den Wall Bake AW; Prince SJ; Julian BA; Tseng ML; Radl J; Elson CO; Mestecky J
Clin Exp Immunol; 1994 May; 96(2):356-63. PubMed ID: 8187345
[TBL] [Abstract][Full Text] [Related]
31. Human salivary immunoglobulin and antigen-specific antibody activity after tonsillectomy.
Childers NK; Powell WD; Tong G; Kirk K; Wiatrak B; Michalek SM
Oral Microbiol Immunol; 2001 Oct; 16(5):265-9. PubMed ID: 11555302
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus transformation of B lymphocytes from IgA nephropathy patients and first-degree relatives results in increased immunoglobulin synthesis not restricted to IgA.
Jackson S; Galla JH; Kirk KA; Thorn BT; Julian BA
Am J Kidney Dis; 1991 Jan; 17(1):55-61. PubMed ID: 1846059
[TBL] [Abstract][Full Text] [Related]
33. Nasal immunization with tetanus toxoid increases the subsequent systemic dimeric IgA1 antibody response to intramuscular immunization.
Waldo FB
J Clin Lab Immunol; 1991 Mar; 34(3):125-9. PubMed ID: 1667944
[TBL] [Abstract][Full Text] [Related]
34. IgA-containing immune complexes in the urine of IgA nephropathy patients.
Matousovic K; Novak J; Yanagihara T; Tomana M; Moldoveanu Z; Kulhavy R; Julian BA; Konecny K; Mestecky J
Nephrol Dial Transplant; 2006 Sep; 21(9):2478-84. PubMed ID: 16757497
[TBL] [Abstract][Full Text] [Related]
35. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies.
Lue C; Tarkowski A; Mestecky J
J Immunol; 1988 Jun; 140(11):3793-800. PubMed ID: 3372993
[TBL] [Abstract][Full Text] [Related]
36. [IgA nephropathy--IgA1 disease].
Maksić D; Marić M; Mijusković Z; Dimitrijević J; Kovacević Z; Jovanović D
Vojnosanit Pregl; 1996; 53(4):293-6. PubMed ID: 9229944
[TBL] [Abstract][Full Text] [Related]
37. Dendritic cells of IgA nephropathy patients have an impaired capacity to induce IgA production in naïve B cells.
Eijgenraam JW; Woltman AM; Kamerling SW; Briere F; de Fijter JW; Daha MR; van Kooten C
Kidney Int; 2005 Oct; 68(4):1604-12. PubMed ID: 16164637
[TBL] [Abstract][Full Text] [Related]
38. Application of Oxford classification, and overexpression of transforming growth factor-β1 and immunoglobulins in immunoglobulin A nephropathy: correlation with World Health Organization classification of immunoglobulin A nephropathy in a Chinese patient cohort.
Meng H; Zhang L; E X; Ye F; Li H; Han C; Yamakawa M; Jin X
Transl Res; 2014 Jan; 163(1):8-18. PubMed ID: 23891568
[TBL] [Abstract][Full Text] [Related]
39. Gluten sensitivity in patients with IgA nephropathy.
Smerud HK; Fellström B; Hällgren R; Osagie S; Venge P; Kristjánsson G
Nephrol Dial Transplant; 2009 Aug; 24(8):2476-81. PubMed ID: 19332868
[TBL] [Abstract][Full Text] [Related]
40. Malignant hypertension in IgA nephropathy was not associated with background pathological phenotypes of glomerular lesions.
Jiang L; Zhang JJ; Lv JC; Liu G; Zou WZ; Zhao MH; Zhang H
Nephrol Dial Transplant; 2008 Dec; 23(12):3921-7. PubMed ID: 18603547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
